Category: News

Researchers out of the University of Toronto are working on a new approach to fight the COVID-19 outbreak using antivirals. BioCanRx network member Dr. Sachdev Sidhu is leading the team, who will “apply their protein engineering technology to identify promising therapeutics”.   Read more from the University of Toronto

A Message from Dr. John Bell, Scientific Director and Dr. Stéphanie Michaud, President & CEO BioCanRx     On World Cancer Day, BioCanRx recommits to working towards a cancer-free reality. Continuing from last year’s theme, the message of World Cancer Day 2020 is “I am and I will”, a phrase that begs action and speaks… Read more »

The participants of the 2019 BioCanRx-Cancer Stakeholder Alliance Learning Institute wish to share their Community Dissemination Report with the oncology patient and researcher community, BioCanRx, the Cancer Stakeholder Alliance, and the general public.   In this report, you will find the key research take-away messages and the Learning Institute’s group reflections on the topics listed… Read more »

The Ottawa Hospital’s Dr. John Bell, BioCanRx’s Scientific Director, spoke with Jason Tetro for Curious Cast’s Super Awesome Science Show about oncolytic viruses & cancer immunotherapy treatment! Click the image to listen!  

  Victoria, BC, was the back drop for BioCanRx’s fourth scientific conference. From October 20 to 23, 2019, the Summit for Cancer Immunotherapy (Summit4CI) brought together 300 delegates including leading scientists, clinicians, trainees, economists and representatives from industry, patient groups, charities and government.   Summit4CI explored the latest cancer immunotherapy developments from scientific, clinical patient… Read more »

The third BioCanRx-Cancer Stakeholder Alliance Learning Institute took place at this year’s Summit for Cancer Immunotherapy. This initiative brought together patient/caregiver leaders and Highly Qualified Personnel in an interactive and collaborative knowledge exchange program. We asked two of the participants, a patient scholar and an academic scholar, to tell us about their experience.    … Read more »

By Adam Nelson, Dalhousie University and Shirin Lak, University of Montreal, CR-HMR   We’ve recently concluded the fourth annual Summit for Cancer Immunotherapy (Summit4CI) in Victoria, British Columbia! The conference this year was an immense success and provided a learning and networking opportunity for undergraduate and graduate students, post-doctoral fellows, faculty, technical staff and patients…. Read more »

Another summer has already come and gone, and that means that the 15 undergraduate students who embarked on a BioCanRx-funded research internship in cancer immunotherapeutics have also taken their leave. We are so proud of the way our summer students have learned and developed, and we want to extend our best wishes to them for… Read more »

By Heather Blumenthal   It just doesn’t sound good – triple negative breast cancer, commonly abbreviated as TNBC. It sounds a lot like starting out with three strikes against you.   And it’s not good. Some 10-20% of Canadian women diagnosed with breast cancer have the triple negative variety. It means that the three most… Read more »

By: The Sunday Edition, CBC Radio   Slash, burn and poison. For decades, these have been largely the only treatment methods available for cancer. But surgery, radiation and chemotherapy do not offer hope to all cancer patients, and even those whose cancer does go into remission are often made sick by the treatment.   It’s… Read more »